In summary, impaired pancreatic beta-cell function plays a pivotal role in the development of abnormal glucose tolerance in MIDD, with a potential modulating effect of decreased whole body insulin sensitivity that may well result from secondary factors such as hyperglycemia and decreased exercise capacity. The gene discussed is INS; the disease is maternally-inherited diabetes and deafness.